Pregnolia Company
Pregnolia ensures that every woman can have a happy, healthy and informed pregnancy until term. Their team knows that the existing research about preterm birth assessment is very promising, but this alone does not guarantee success. Sabrina, Francisco and Annette are highly committed to develop the commercial version of the device, complete the clinical trial, follow the regulatory roadmap and execute on their business vision to successfully support gynaecologists in improving the preterm birth risk assessment and birth management.
Investors
Headquarters:
Switzerland
Industry:
Sensing/Imaging/Diagnostics
Super Industry:
Quantum Medicine
Funding Total Value:
10622374
Founders:
Francisco Delgado, Sabrina Badir
Phone Number:
41 44 500 84 35
Investors:
EIC Accelerator, Redstone.VC, Venture Kick, Verve Ventures, Z?rcher Kantonal Bank
Ipo Status:
private
City:
Schlieren
Region:
Zurich
Country:
Switzerland
















